Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels

Channels

Volumn 6, Issue 3, 2012, Pages 181-196

  Meighan, Peter C ^a   Meighan, Starla E ^a   Rich, Elizabeth D ^a   Brown, R Lane ^a   Varnum, Michael D ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cone; Cyclic nucleotide gated channel; Extracellular protease; Gating; Matrix metalloproteinase; Photoreceptor; Rod

Indexed keywords

CYCLIC AMP; CYCLIC NUCLEOTIDE GATED CHANNEL; GELATINASE A; GELATINASE B; INTEGRIN; LIGAND;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NONHUMAN; PHOTORECEPTOR; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETINA CONE; RETINA ROD;

MUS;

EID: 84864476947     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.20904     Document Type: Article

References (84)

1. Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008; 29:290-308; PMID:18619669; http://dx.doi.org/10.1016/j.mam. 2008.05.002.
2. Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006; 26:1923-34; PMID:16481424; http://dx.doi.org/10.1523/JNEUROSCI.4359-05.2006.
3. Meighan PC, Meighan SE, Davis CJ, Wright JW, Harding JW. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. J Neurochem 2007; 102:2085-96; PMID:17587312; http://dx.doi.org/10.1111/j.1471-4159.2007.04682.x.
4. Bilousova TV, Rusakov DA, Ethell DW, Ethell IM. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J Neurochem 2006; 97:44-56; PMID:16515559; http://dx.doi.org/10.1111/j.1471-4159.2006.03701.x.
5. Tian L, Stefanidakis M, Ning L, Van Lint P, Nyman-Huttunen H, Libert C, et al. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 2007; 178:687-700; PMID:17682049; http://dx.doi.org/10.1083/jcb.200612097.
6. Wang XB, Bozdagi O, Nikitczuk JS, Zhai ZW, Zhou Q, Huntley GW. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci USA 2008; 105:19520-5; PMID:19047646; http://dx.doi.org/10.1073/pnas.0807248105.
7. Wójtowicz T, Mozrzymas JW. Late phase of longterm potentiation in the mossy fiber-CA3 hippocampal pathway is critically dependent on metalloproteinases activity. Hippocampus 2010; 20:917-21; PMID:20572195.
8. Meighan SE, Meighan PC, Choudhury P, Davis CJ, Olson ML, Zornes PA, et al. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 2006; 96:1227-41; PMID:16464240; http://dx.doi.org/10.1111/j.1471- 4159.2005.03565.x.
9. Nagy V, Bozdagi O, Huntley GW. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learn Mem 2007; 14:655-64; PMID:17909100; http://dx.doi.org/10.1101/lm.678307.
10. Olson ML, Meighan PC, Brown TE, Asay AL, Benoist CC, Harding JW, et al. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. Regul Pept 2008; 146:19-25; PMID:17698214; http://dx.doi.org/10.1016/j.regpep. 2007.07.004.
11. Szklarczyk A, Lapinska J, Rylski M, McKay RDG, Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002; 22:920-30; PMID:11826121.
12. Kim HJ, Fillmore HL, Reeves TM, Phillips LL. Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis. Exp Neurol 2005; 192:60-72; PMID:15698619; http://dx.doi.org/10.1016/j.expneurol.2004.10. 014.
13. Agrawal SM, Lau L, Yong VW. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008; 19:42-51; PMID:17646116; http://dx.doi.org/10.1016/j.semcdb.2007.06.003.
14. Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, Zhang N, et al. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 2010; 67:199-212; PMID:20670829; http://dx.doi.org/10.1016/j.neuron.2010.06.021.
15. Yang Y, Hill JW, Rosenberg GA. Chapter 6 - multiple roles of metalloproteinases in neurological disorders. Prog Mol Biol Transl Sci 2011; 99:241-63.
16. Plantner JJ, Drew TA. Polarized distribution of metalloproteinases in the bovine interphotoreceptor matrix. Exp Eye Res 1994; 59:577-85; PMID:9492759; http://dx.doi.org/10.1006/exer.1994.1143.
17. Padgett LC, Lui GM, Werb Z, LaVail MM. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Exp Eye Res 1997; 64:927-38; PMID:9301473; http://dx.doi.org/10.1006/exer.1997.0287.
18. Smine A, Plantner JJ. Membrane type-1 matrix metalloproteinase in human ocular tissues. Curr Eye Res 1997; 16:925-9; PMID:9288454; http://dx.doi.org/10. 1076/ceyr.16.9.925.5044.
19. Plantner JJ, Smine A, Quinn TA. Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr Eye Res 1998; 17:132-40; PMID:9523090; http://dx.doi.org/10.1076/ceyr.17.2. 132.5610.
20. Zhang X, Cheng M, Chintala SK. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci 2004; 45:2374-83; PMID:15223820; http://dx.doi.org/10.1167/iovs.03-1239.
21. Mali RS, Cheng M, Chintala SK. Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Invest Ophthalmol Vis Sci 2005; 46:2125-32; PMID:15914633; http://dx.doi.org/ 10.1167/iovs.04-1376.
22. Papp AM, Nyilas R, Szepesi Z, Lorincz ML, Takács E, Abrahám I, et al. Visible light induces matrix metalloproteinase-9 expression in rat eye. J Neurochem 2007; 103:2224-33; PMID:17854381; http://dx.doi.org/10.1111/j. 1471-4159.2007.04917.x.
23. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21:1-14; PMID:11906808; http://dx.doi.org/10.1016/S1350-9462(01)00015-5.
24. Majka S, McGuire P, Colombo S, Das A. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy. Invest Ophthalmol Vis Sci 2001; 42:210-5; PMID:11133870.
25. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 2005; 85:597-607; PMID:15711567; http://dx.doi.org/10.1038/ labinvest.3700251.
26. Kowluru RA. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci 2010; 51:4320-6; PMID:20220057; http://dx.doi.org/10.1167/iovs.09-4851.
27. Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998; 67:637-45; PMID:9990329; http://dx.doi.org/10.1006/exer.1998.0552.
28. Chen YD, Xu X, Xia X, Wu H, Liu K, Zheng Z, et al. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline. Curr Eye Res 2008; 33:977-83; PMID:19085380; http://dx.doi.org/10.1080/02713680802450984.
29. Macgregor AM, Eberhart CG, Fraig M, Lu J, Halushka MK. Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney and eye increase with age. J Histochem Cytochem 2009; 57:207-13; PMID:18955737; http://dx.doi.org/10.1369/jhc.2008.952531.
30. Liutkeviciene R, Lesauskaite V, Asmoniene V, Zali niene D, Jasinskas V. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 2010; 46:89-94; PMID:20440081.
31. Mathalone N, Lahat N, Rahat MA, Bahar-Shany K, Oron Y, Geyer O. The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia. Graefes Arch Clin Exp Ophthalmol 2007; 245:725-32; PMID:17024442; http://dx.doi.org/10.1007/s00417-006-0362-y.
32. Ahuja S, Ahuja P, Caffé AR, Ekstrom P, Abrahamson M, van Veen T. rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans. Ophthalmic Res 2006; 38:125-36; PMID:16374054; http://dx.doi.org/10.1159/000090533.
33. Chintala SK. The emerging role of proteases in retinal ganglion cell death. Exp Eye Res 2006; 82:5-12; PMID:16185688; http://dx.doi.org/10.1016/j. exer.2005.07.013.
34. Szklarczyk A, Ewaleifoh O, Beique JC, Wang Y, Knorr D, Haughey N, et al. MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J 2008; 22:3757-67; PMID:18644839; http://dx.doi.org/10.1096/fj.07- 101402.
35. Pauly T, Ratliff M, Pietrowski E, Neugebauer R, Schlicksupp A, Kirsch J, et al. Activity-dependent shedding of the NMDA receptor glycine binding site by matrix metalloproteinase 3: a PUTATIVE mechanism of postsynaptic plasticity. PLoS One 2008; 3:2681; PMID:18629001; http://dx.doi.org/10.1371/journal.pone. 0002681.
36. Rangaraju S, Khoo KK, Feng ZP, Crossley G, Nugent D, Khaytin I, et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem 2010; 285:9124-36; PMID:19965868; http://dx.doi.org/10.1074/jbc.M109. 071266.
37. Craven KB, Zagotta WN. CNG and HCN channels: two peas, one pod. Annu Rev Physiol 2006; 68:375-401; PMID:16460277; http://dx.doi.org/10.1146/annurev. physiol.68.040104.134728.
38. Pifferi S, Boccaccio A, Menini A. Cyclic nucleotide-gated ion channels in sensory transduction. FEBS Lett 2006; 580:2853-9; PMID:16631748; http://dx.doi.org/10.1016/j.febslet.2006.03.086.
39. Garcia-Caballero A, Ishmael SS, Dang Y, Gillie D, Bond JS, Milgram SL, et al. Activation of the epithelial sodium channel by the metalloprotease meprin β-subunit. Channels (Austin) 2011; 5:14-22; PMID:20953144; http://dx.doi.org/10.4161/chan.5.1.13759.
40. Bright SR, Rich ED, Varnum MD. Regulation of human cone cyclic nucleotide-gated channels by endogenous phospholipids and exogenously applied phosphatidylinositol-3,4,5-trisphosphate. Mol Pharmacol 2007; 71:176-83; PMID:17018579; http://dx.doi.org/10.1124/mol.106.026401.
41. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986; 261:14245-55; PMID:3095317.
42. Michaluk P, Mikasova L, Groc L, Frischknecht R, Choquet D, Kaczmarek L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. J Neurosci 2009; 29:6007-12; PMID:19420267; http://dx.doi.org/10.1523/JNEUROSCI.5346-08.2009.
43. Conant K, Lonskaya I, Szklarczyk A, Krall C, Steiner J, Maguire-Zeiss K, et al. Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. J Neurochem 2011; 118:521-32; PMID:21166806; http://dx.doi.org/10.1111/j.1471-4159.2010.07153.x.
44. Puente XS, Sánchez LM, Overall CM, López-Otín C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 2003; 4:544-58; PMID:12838346; http://dx.doi.org/10.1038/nrg1111.
45. Liu C, Varnum MD. Functional consequences of progressive cone dystrophy-associated mutations in the human cone photoreceptor cyclic nucleotide-gated channel CNGA3 subunit. Am J Physiol Cell Physiol 2005; 289:187-98; PMID:15743887; http://dx.doi.org/10.1152/ajpcell.00490.2004.
46. Faillace MP, Bernabeu RO, Korenbrot JI. Cellular processing of cone photoreceptor cyclic GMP-gated ion channels: a role for the S4 structural motif. J Biol Chem 2004; 279:22643-53; PMID:15024024; http://dx.doi.org/10.1074/jbc. M400035200.
47. Pugh EN Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta 1993; 1141:111-49; PMID:8382952; http://dx.doi.org/10.1016/0005-2728(93)90038-H.
48. Kaupp UB, Niidome T, Tanabe T, Terada S, Bönigk W, Stühmer W, et al. Primary structure and functional expression from complementary DNA of the rod photoreceptor cyclic GMP-gated channel. Nature 1989; 342:762-6; PMID:2481236; http://dx.doi.org/10.1038/342762a0.
49. Chen TY, Peng YW, Dhallan RS, Ahamed B, Reed RR, Yau KW. A new subunit of the cyclic nucleotide-gated cation channel in retinal rods. Nature 1993; 362:764-7; PMID:7682292; http://dx.doi.org/10.1038/362764a0.
50. Chen TY, Illing M, Molday LL, Hsu YT, Yau KW, Molday RS. Subunit 2 (or beta) of retinal rod cGMP-gated cation channel is a component of the 240-kDa channel-associated protein and mediates Ca(2+)-calmodulin modulation. Proc Natl Acad Sci USA 1994; 91:11757-61; PMID:7526403; http://dx.doi.org/10.1073/pnas.91. 24.11757.
51. Körschen HG, Illing M, Seifert R, Sesti F, Williams A, Gotzes S, et al. A 240 kDa protein represents the complete beta subunit of the cyclic nucleotide-gated channel from rod photoreceptor. Neuron 1995; 15:627-36; PMID:7546742; http://dx.doi.org/10.1016/0896-6273(95)90151-5.
52. Molokanova E, Trivedi B, Savchenko A, Kramer RH. Modulation of rod photoreceptor cyclic nucleotide-gated channels by tyrosine phosphorylation. J Neurosci 1997; 17:9068-76; PMID:9364053.
53. Gerstner A, Zong X, Hofmann F, Biel M. Molecular cloning and functional characterization of a new modulatory cyclic nucleotide-gated channel subunit from mouse retina. J Neurosci 2000; 20:1324-32; PMID:10662822.
54. Zhong H, Molday LL, Molday RS, Yau KW. The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry. Nature 2002; 420:193-8; PMID:12432397; http://dx.doi.org/10.1038/nature01201.
55. Weitz D, Ficek N, Kremmer E, Bauer PJ, Kaupp UB. Subunit stoichiometry of the CNG channel of rod photoreceptors. Neuron 2002; 36:881-9; PMID:12467591; http://dx.doi.org/10.1016/S0896-6273(02)01098-X.
56. Zheng J, Trudeau MC, Zagotta WN. Rod cyclic nucleotide-gated channels have a stoichiometry of three CNGA1 subunits and one CNGB1 subunit. Neuron 2002; 36:891-6; PMID:12467592; http://dx.doi.org/10.1016/S0896-6273(02)01099-1.
57. Peng C, Rich ED, Varnum MD. Subunit configuration of heteromeric cone cyclic nucleotide-gated channels. Neuron 2004; 42:401-10; PMID:15134637; http://dx.doi.org/10.1016/S0896-6273(04)00225-9.
58. Haynes LW, Kay AR, Yau KW. Single cyclic GMP-activated channel activity in excised patches of rod outer segment membrane. Nature 1986; 321:66-70; PMID:2422558; http://dx.doi.org/10.1038/321066a0.
59. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 1994; 14:1315-20; PMID:8049193; http://dx.doi.org/10.1161/01.ATV.14.8.1315.
60. Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs. Oxford University Press USA 2000; 2.
61. Conant K, Wang Y, Szklarczyk A, Dudak A, Mattson MP, Lim ST. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 2010; 166:508-21; PMID:20045450; http://dx.doi.org/10.1016/j.neuroscience.2009.12.061.
62. Molokanova E, Maddox F, Luetje CW, Kramer RH. Activity-dependent modulation of rod photoreceptor cyclic nucleotide-gated channels mediated by phosphorylation of a specific tyrosine residue. J Neurosci 1999; 19:4786-95; PMID:10366613.
63. Gordon SE, Oakley JC, Varnum MD, Zagotta WN. Altered ligand specificity by protonation in the ligand binding domain of cyclic nucleotide-gated channels. Biochemistry 1996; 35:3994-4001; PMID:8672432; http://dx.doi.org/10.1021/ bi952607b.
64. Ruiz M, Brown RL, He Y, Haley TL, Karpen JW. The single-channel dose-response relation is consistently steep for rod cyclic nucleotide-gated channels: implications for the interpretation of macroscopic dose-response relations. Biochemistry 1999; 38:10642-8; PMID:10451358; http://dx.doi.org/10. 1021/bi990532w.
65. Kleyman TR, Carattino MD, Hughey RP. ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem 2009; 284:20447-51; PMID:19401469; http://dx.doi.org/10.1074/jbc.R800083200.
66. Kitamura K, Tomita K. Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors. Clin Exp Nephrol 2010; 14:405-10; PMID:20535627; http://dx.doi.org/10.1007/s10157-010- 0299-7.
67. Jones BE, Moshyedi P, Gallo S, Tombran-Tink J, Arand G, Reid DA, et al. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium. Exp Eye Res 1994; 59:257-69; PMID:7821370; http://dx.doi.org/10.1006/exer.1994.1107.
68. Ko GY, Ko ML, Dryer SE. Developmental expression of retinal cone cGMP-gated channels: evidence for rapid turnover and trophic regulation. J Neurosci 2001; 21:221-9; PMID:11150339.
69. Ko GYP, Ko ML, Dryer SE. Circadian Regulation of cGMP-Gated Cationic Channels of Chick Retinal Cones. Neuron 2001; 29:255-66; PMID:11182096; http://dx.doi.org/10.1016/S0896-6273(01)00195-7.
70. Paquet-Durand F, Beck S, Michalakis S, Goldmann T, Huber G, Mühlfriedel R, et al. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. Hum Mol Genet 2011; 20:941-7; PMID:21149284; http://dx.doi.org/10.1093/hmg/ddq539.
71. Huang SH, Pittler SJ, Huang X, Oliveira L, Berson EL, Dryja TP. Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet 1995; 11:468-71; PMID:7493036; http://dx.doi.org/10.1038/ng1295-468.
72. Payne AM, Downes SM, Bessant DA, Taylor R, Holder GE, Warren MJ, et al. A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet 1998; 7:273-7; PMID:9425234; http://dx.doi.org/10.1093/hmg/7.2.273.
73. Biel M, Michalakis S. Function and dysfunction of CNG channels: insights from channelopathies and mouse models. Mol Neurobiol 2007; 35:266-77; PMID:17917115; http://dx.doi.org/10.1007/s12035-007-0025-y.
74. Fox DA, Poblenz AT, He L. Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. Ann NY Acad Sci 1999; 893:282-5; PMID:10672249; http://dx.doi.org/10.1111/j. 1749-6632.1999.tb07837.x.
75. Yu WP, Grunwald ME, Yau KW. Molecular cloning, functional expression and chromosomal localization of a human homolog of the cyclic nucleotide-gated ion channel of retinal cone photoreceptors. FEBS Lett 1996; 393:211-5; PMID:8814292; http://dx.doi.org/10.1016/0014-5793(96)00889-7.
76. Peng C, Rich ED, Thor CA, Varnum MD. Functionally important calmodulin-binding sites in both NH2- and COOH-terminal regions of the cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit. J Biol Chem 2003; 278:24617-23; PMID:12730238; http://dx.doi.org/10.1074/jbc.M301699200.
77. Schoenmakers TJ, Visser GJ, Flik G, Theuvenet AP. CHELATOR: an improved method for computing metal ion concentrations in physiological solutions. Biotechniques 1992; 12:870-4; PMID:1642895.
78. Gordon SE, Zagotta WN. Localization of regions affecting an allosteric transition in cyclic nucleotide-activated channels. Neuron 1995; 14:857-64; PMID:7536427; http://dx.doi.org/10.1016/0896-6273(95)90229-5.
79. Varnum MD, Black KD, Zagotta WN. Molecular mechanism for ligand discrimination of cyclic nucleotide-gated channels. Neuron 1995; 15:619-25; PMID:7546741; http://dx.doi.org/10.1016/0896-6273(95)90150-7.
80. Fodor AA, Gordon SE, Zagotta WN. Mechanism of tetracaine block of cyclic nucleotide-gated channels. J Gen Physiol 1997; 109:3-14; PMID:8997661; http://dx.doi.org/10.1085/jgp.109.1.3.
81. Li J, Zagotta WN, Lester HA. Cyclic nucleotide-gated channels: structural basis of ligand efficacy and allosteric modulation. Q Rev Biophys 1997; 30:177-93; PMID:9293605; http://dx.doi.org/10.1017/S0033583597003326.
82. Molday RS, Molday LL, Dosé A, Clark-Lewis I, Illing M, Cook NJ, et al. The cGMP-gated channel of the rod photoreceptor cell characterization and orientation of the amino terminus. J Biol Chem 1991; 266:21917-22; PMID:1718987.
83. Holm S. A simple sequentially rejective multiple test proceedure. Scand J Stat 1979; 6:65-70.
84. Sakmann B, Neher E. Single-Channel Recording. Springer 1995; 2.